GB0905120D0 - Buprenorphine-containing non-pressurised spray composition for transmucisal administration - Google Patents
Buprenorphine-containing non-pressurised spray composition for transmucisal administrationInfo
- Publication number
- GB0905120D0 GB0905120D0 GBGB0905120.2A GB0905120A GB0905120D0 GB 0905120 D0 GB0905120 D0 GB 0905120D0 GB 0905120 A GB0905120 A GB 0905120A GB 0905120 D0 GB0905120 D0 GB 0905120D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- transmucisal
- buprenorphine
- administration
- containing non
- spray composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0620661.9A GB0620661D0 (en) | 2006-10-18 | 2006-10-18 | Novel compounds |
PCT/GB2007/050639 WO2008047163A1 (en) | 2006-10-18 | 2007-10-17 | Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0905120D0 true GB0905120D0 (en) | 2009-05-06 |
GB2456434A GB2456434A (en) | 2009-07-22 |
Family
ID=37507923
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0620661.9A Ceased GB0620661D0 (en) | 2006-10-18 | 2006-10-18 | Novel compounds |
GB0905120A Withdrawn GB2456434A (en) | 2006-10-18 | 2009-03-25 | Buprenorphine-containing non-pressurised spray composition for transmucosal administration |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0620661.9A Ceased GB0620661D0 (en) | 2006-10-18 | 2006-10-18 | Novel compounds |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP2081574A1 (en) |
CN (1) | CN101573116A (en) |
AU (1) | AU2007311621A1 (en) |
CA (1) | CA2666581A1 (en) |
GB (2) | GB0620661D0 (en) |
IL (1) | IL197908A0 (en) |
WO (1) | WO2008047163A1 (en) |
ZA (1) | ZA200902123B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
BRPI0714712B8 (en) | 2006-07-21 | 2021-05-25 | Biodelivery Sciences Int Inc | drug delivery device |
GB2461681A (en) * | 2008-04-17 | 2010-01-13 | Pharmasol Ltd | Buprenorphine liquid spray formulation with solvent and antioxidant |
MX337286B (en) | 2007-05-25 | 2016-02-22 | Indivior Uk Ltd | Sustained delivery formulations of risperidone compounds. |
WO2010072398A2 (en) * | 2008-12-22 | 2010-07-01 | Boehringer Ingelheim Limited | Veterinary formulations |
GB2513060B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
GB2481619B (en) * | 2010-06-30 | 2012-06-20 | Londonpharma Ltd | Formulations and delivery devices for the sublingual administration of opioids |
US9901539B2 (en) | 2011-12-21 | 2018-02-27 | Biodelivery Sciences International, Inc. | Transmucosal drug delivery devices for use in chronic pain relief |
SG11201403075XA (en) * | 2011-12-21 | 2014-07-30 | Biodelivery Sciences Int Inc | Transmucosal drug delivery devices for use in chronic pain relief |
GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
WO2017075256A1 (en) | 2015-10-27 | 2017-05-04 | Insys Development Company, Inc. | Liquid buprenorphine formulations |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030190290A1 (en) * | 2000-06-22 | 2003-10-09 | Calvin Ross | Pharmaceutical compositions |
JP2005503425A (en) * | 2001-05-24 | 2005-02-03 | アレックザ モレキュラー デリヴァリー コーポレイション | Delivery of drug ester by the prescribed inhalation route |
JP2006516963A (en) * | 2003-02-04 | 2006-07-13 | クリサリス テクノロジーズ インコーポレイテッド | Aerosol formulation and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem |
ES2559410T3 (en) * | 2004-04-23 | 2016-02-12 | Philip Morris Products S.A. | Aerosol generators and methods for producing aerosols |
-
2006
- 2006-10-18 GB GBGB0620661.9A patent/GB0620661D0/en not_active Ceased
-
2007
- 2007-10-17 CA CA002666581A patent/CA2666581A1/en not_active Abandoned
- 2007-10-17 AU AU2007311621A patent/AU2007311621A1/en not_active Abandoned
- 2007-10-17 WO PCT/GB2007/050639 patent/WO2008047163A1/en active Application Filing
- 2007-10-17 EP EP07824851A patent/EP2081574A1/en not_active Withdrawn
- 2007-10-17 CN CNA2007800387417A patent/CN101573116A/en active Pending
-
2009
- 2009-03-25 GB GB0905120A patent/GB2456434A/en not_active Withdrawn
- 2009-03-26 ZA ZA200902123A patent/ZA200902123B/en unknown
- 2009-04-05 IL IL197908A patent/IL197908A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007311621A1 (en) | 2008-04-24 |
IL197908A0 (en) | 2009-12-24 |
ZA200902123B (en) | 2010-04-28 |
GB2456434A (en) | 2009-07-22 |
WO2008047163A1 (en) | 2008-04-24 |
CA2666581A1 (en) | 2008-04-24 |
GB0620661D0 (en) | 2006-11-29 |
EP2081574A1 (en) | 2009-07-29 |
CN101573116A (en) | 2009-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0905120D0 (en) | Buprenorphine-containing non-pressurised spray composition for transmucisal administration | |
IL195246A0 (en) | Atomiser | |
EP2001498A4 (en) | Pharmaceutical compositions | |
IL194176A0 (en) | Pharmaceutical compositions | |
GB0713625D0 (en) | Pharmaceutical compositions | |
HK1138732A1 (en) | Pharmaceutical compositions | |
EP2043136A4 (en) | Film-forming composition | |
ZA200806929B (en) | Nebulizer formulation | |
GB0716905D0 (en) | Nozzle | |
GB2443162B (en) | Betamethasone spray | |
GB0609434D0 (en) | Spray nozzle | |
EP2124959A4 (en) | Pharmaceutical composition | |
GB0617808D0 (en) | Nozzle | |
EP2109454A4 (en) | Glp-1 pharmaceutical compositions | |
GB2443161B (en) | Clobetasol spray | |
GB0607667D0 (en) | Spray nozzle | |
EP1983874A4 (en) | Nozzle | |
GB0515212D0 (en) | Compositions for intranasal administration | |
GB0612696D0 (en) | Pharmaceutical composition | |
GB0617578D0 (en) | Pharmaceutical composition | |
GB0600032D0 (en) | Pharmaceutical composition | |
GB0605740D0 (en) | Spray | |
ZA200904725B (en) | GLP-1 Pharmaceutical compositions | |
GB0622066D0 (en) | Nozzle | |
GB0621623D0 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |